Core Points - Indian drug regulatory authorities conducted inspections revealing serious violations in several pharmaceutical companies, particularly regarding the testing of drug raw materials for each batch [1][2] - At least 17 children under the age of five have died after consuming cough syrups containing toxic substances, with the levels of diethylene glycol reaching nearly 500 times the permissible limit [2] Group 1: Regulatory Actions - The inspections were prompted by previous findings of "substandard drugs" from the companies involved [1] - The Gujarat state government has ordered an immediate halt to all production and sales activities of the two inspected companies [2] - The company "Sresan Pharmaceuticals" has had its offices and factories shut down, and police are investigating the firm for "murder" charges [2] Group 2: Export Concerns - The cough syrups in question were reportedly sold only within India, but the World Health Organization is seeking clarification on whether these products were exported to other countries [2] - Indian pharmaceuticals are widely exported to developing countries, and there are concerns about the association of toxic cough syrups with the deaths of over 140 children in countries like Gambia, Uzbekistan, and Cameroon [2]
印度“毒糖浆”已致17名儿童死亡 多家药企被查出违规
Xin Hua She·2025-10-09 03:08